Kelly Financial Services’s Immunogen Inc IMGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q1
Sell
-100
Closed -$2.96K 836
2023
Q4
$2.96K Hold
100
﹤0.01% 539
2023
Q3
$1.59K Hold
100
﹤0.01% 570
2023
Q2
$1.89K Hold
100
﹤0.01% 555
2023
Q1
$384 Hold
100
﹤0.01% 645
2022
Q4
$496 Hold
100
﹤0.01% 606
2022
Q3
$478 Hold
100
﹤0.01% 615
2022
Q2
$450 Hold
100
﹤0.01% 609
2022
Q1
$476 Hold
100
﹤0.01% 613
2021
Q4
$742 Hold
100
﹤0.01% 599
2021
Q3
$567 Sell
100
-559
-85% -$3.23K ﹤0.01% 594
2021
Q2
$100K Buy
659
+559
+559% +$3.9K ﹤0.01% 387
2021
Q1
$810 Hold
100
﹤0.01% 560
2020
Q4
$645 Hold
100
﹤0.01% 533
2020
Q3
$360 Hold
100
﹤0.01% 529
2020
Q2
$460 Hold
100
﹤0.01% 534
2020
Q1
$341 Sell
100
-220
-69% -$962 ﹤0.01% 514
2019
Q4
$1.63K Buy
320
+220
+220% +$747 ﹤0.01% 433
2019
Q3
$242 Hold
100
﹤0.01% 509
2019
Q2
$217 Hold
100
﹤0.01% 468
2019
Q1
$271 Buy
+100
New +$433 ﹤0.01% 457

Other funds holding IMGN

Kelly Financial Services's IMGN Position: Q1 2024 in Review

Kelly Financial Services sold out of Immunogen Inc (IMGN) in Q1 2024, closing a stake of 100 shares — an estimated $2.96K sold.

Kelly Financial Services first reported a position in IMGN in Q1 2019 and held it in 20 quarters. The position peaked at $100K in Q2 2021. 3 funds tracked by Wall St. Rank hold IMGN as of Q1 2024.

  • Kelly Financial Services reported no remaining Immunogen Inc position as of Q1 2024 after selling out during the quarter.
  • Kelly Financial Services sold 100 Immunogen Inc shares in Q1 2024, an estimated $2.96K.
  • Kelly Financial Services first reported a position in Immunogen Inc in Q1 2019 and held it in 20 quarters.
  • Kelly Financial Services's Immunogen Inc position peaked at $100K in Q2 2021.
  • 3 funds tracked by Wall St. Rank held Immunogen Inc as of Q1 2024.

Based on Kelly Financial Services's 13F filing for Q1 2024, filed 17 Jul 2024.